CompletedPhase 1NCT03103009
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Principal Investigator
- Helen Lawler, MDUniversity of Colorado, Denver
- Intervention
- Pasireotide(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2017
Study locations (1)
- University of Colorado Denver, Aurora, Colorado, United States
Collaborators
Novartis
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03103009 on ClinicalTrials.gov